POST COVID RHINOORBITAL MUCORMYCOSIS (ROM) - OUR EXPERIENCE IN MANAGEMENT OF DISEASE, ON A SIX MONTH FOLLOW UP OF 60 PATIENTS.
Vijaypradap R
, Rajavel MSPS , Maheswaran S , RamaPriyadharshini J , Nithin ragav G
Mucormycosis, invasive fungal sinusitis, rhino orbital mucormycosis, Acute fungal sinusitis, Fungal sinusitis, Management of Mucormycosis, Treatment of Mucormycosis, Acute sinusitis, Orbital apex syndrome, Maxillectomy, Orbital exenteration, COVID 19 related Mucormycosis, Mucormycosis epidemic
AIM: Observe the treatment outcome of the patients treated for Post COVID ROM in a tertiary care hospital with 6 month follow up. MATERIALS AND METHODS All patients diagnosed for Post COVID ROM were included in this study. All these patients were subjected to surgical debridement and anti-fungal treatment. The patients were followed up for a period of 6 months and outcome was evaluated based on the postoperative morbidity. RESULTS 60 patients were included in the study. 44 patients had limited disease. 16 patients had extensive disease. All patients underwent surgical debridement and anti-fungal treatment. Repeat imaging was done 3 months to assess the treatment outcome. A complete 6 month follow up was done. CONCLUSION In the early stage of the pandemic, patients who presented very late with extensive disease and were subjected to radical surgical debridement which included orbital exenteration. Later ROM was identified earlier and early surgical intervention was started. Early suspicion and aggressive surgical debridement not only had good outcome, but also reduced the post-operative morbidity. In early disease presentation significant reduction in morbidity and reduced recurrence was observed in patients who have undergone Caldwell Luc surgery to examine the maxillary sinus cavity along with endoscopic debridement for disease clearance in the maxillary sinus floor and anterolateral wall. In delayed presentation and in patients needing Maxillectomy, preservation of mucosa of hard palate had significant reduction in postoperative morbidity without increasing the recurrence rate.
"POST COVID RHINOORBITAL MUCORMYCOSIS (ROM) - OUR EXPERIENCE IN MANAGEMENT OF DISEASE, ON A SIX MONTH FOLLOW UP OF 60 PATIENTS. ", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.7, Issue 5, page no.134 - 139, May-2022, Available :https://ijsdr.org/papers/IJSDR2205026.pdf
Volume 7
Issue 5,
May-2022
Pages : 134 - 139
Paper Reg. ID: IJSDR_200327
Published Paper Id: IJSDR2205026
Downloads: 000347282
Research Area: Medical Science
Country: madurai, Tamilnadu, India
ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJSDR(IJ Publication) Janvi Wave
